Clinical drug research in chronic central neurodegenerative disorders.

about

Emerging approaches in Parkinson's disease - adjunctive role of safinamide Pioglitazone for the treatment of Alzheimer's disease.Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias.

P2860

Q26740905-523F1F77-6955-4866-878C-898796D2030E Q39019397-7CFDEF4A-5CD2-4BF4-858F-1AAFC26CC91F Q39324877-47D96EBA-6A45-44C5-B940-289BE35EFAAC

P2860

Clinical drug research in chronic central neurodegenerative disorders.

Item

http://www.wikidata.org/entity/Q38763831

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical drug research in chronic central neurodegenerative disorders.

@en

type

Item

label

Clinical drug research in chronic central neurodegenerative disorders.

@en

prefLabel

Clinical drug research in chronic central neurodegenerative disorders.

@en

P1476

Clinical drug research in chronic central neurodegenerative disorders.

@en

P2093

Paul Foley

http://www.w3.org/2001/XMLSchema#string

Thomas Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Connecting the dots between tau dysfunction and neurodegeneration

Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs

Disease modifying therapies for Alzheimer's disease targeting Aβ oligomers: implications for therapeutic mechanisms

The potential applications of Apolipoprotein E in personalized medicine

Alzheimer's disease progression model based on integrated biomarkers and clinical measures.

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.

Expanding efforts to address Alzheimer's disease: the Healthy Brain Initiative.

Diagnostic staging of Parkinson's disease: conceptual aspects.

Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.

P304

497-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.2016.1163220

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26950806

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

Clinical drug research in chronic central neurodegenerative disorders.

about

P2860

P2860

Clinical drug research in chronic central neurodegenerative disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921